查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417550

生物模拟市场报告：2030 年趋势、预测与竞争分析

Biosimulation Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

生物模拟趋势和预测

预计到 2030 年，全球生物模拟市场将达到 68 亿美元，2024 年至 2030 年复合年增长率为 13.5%。该市场的主要驱动力是生物相似药和生技药品市场的不断扩大、使用模拟软体的监管机构数量的增加以及生物技术和製药领域研发支出的增加。全球生物模拟市场的未来充满希望，为製药和生物技术公司、CRO、监管机构和学术研究机构提供了机会。

生物模拟市场洞察

Lucintel 预计，由于政府鼓励使用先进软体的措施不断增加，药物开发在预测期内仍将占据很大一部分。

由于主要参与者的存在、医疗保健数位化的提高以及慢性健康问题的增加，北美在预测期内仍将是最大的地区。

常问问题

Q1.市场规模有多大？

A1. 到2030年，全球生物模拟市场预计将达到68亿美元。

Q2.市场成长预测如何？

A2. 2024年至2030年，全球生物模拟市场预计将以13.5%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动力是生物仿製药和生物製药市场的扩大、使用模拟软体的监管机构数量的增加以及生物技术和製药领域研发支出的增加。

Q4.市场的主要细分市场是什么？

A4. 生物模拟市场的未来性前景广阔，为製药和生物技术公司、CRO、监管机构和学术研究机构提供了机会。

Q5.市场上主要企业有哪些？

A5. 以下列出了一些主要企业。

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计，由于政府加强鼓励使用复杂软体，药物开发在预测期内仍将占据较大份额。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 由于主要参与者的存在、医疗保健数位化的提高以及慢性健康问题的增加，北美在预测期内将继续成为最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球生物模拟市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球生物模拟市场趋势（2018-2023）与预测（2024-2030）
  • 按交付模式分類的全球生物模拟市场
    • 订阅模式
    • 所有权模式
  • 按产品分類的全球生物模拟市场
    • 软体
    • 服务
  • 按应用分類的全球生物模拟市场
    • 药物开发
    • 药物发现
    • 其他的
  • 按最终用途分類的全球生物模拟市场
    • 製药和生物技术公司
    • CRO
    • 监管机构
    • 学术研究所

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球生物模拟市场
  • 北美生物模拟市场
  • 欧洲生物模拟市场
  • 亚太生物模拟市场
  • 其他地区生物模拟市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按交付模式分類的全球生物模拟市场成长机会
    • 按产品分類的全球生物模拟市场成长机会
    • 按应用分類的全球生物模拟市场成长机会
    • 按最终用途分類的全球生物模拟市场成长机会
    • 按地区分類的全球生物模拟市场成长机会
  • 全球生物模拟市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球生物模拟市场的能力
    • 全球生物模拟市场的併购和合资企业
    • 认证和许可

第七章主要企业概况

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata
简介目录

Biosimulation Trends and Forecast

The future of the global biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research Institution markets. The global biosimulation market is expected to reach an estimated $6.8 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software, and growing R&D expenditures in the biotechnology and pharmaceutical sectors.

A more than 150-page report is developed to help in your business decisions.

Biosimulation by Segment

The study includes a forecast for the global biosimulation by delivery model, product, application, end use, and region.

Biosimulation Market by Delivery Model [Shipment Analysis by Value from 2018 to 2030]:

  • Subscription Models
  • Ownership Models

Biosimulation Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Software
  • Services

Biosimulation Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Drug Development
  • Drug Discovery
  • Others

Biosimulation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Regulatory Authorities
  • Academic Research Institutions

Biosimulation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biosimulation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities aCROss the value chain. With these strategies biosimulation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biosimulation companies profiled in this report include-

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata

Biosimulation Market Insights

Lucintel forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.

North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.

Features of the Global Biosimulation Market

Market Size Estimates: Biosimulation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biosimulation market size by various segments, such as by delivery model, product, application, end use, and region in terms of value ($B).

Regional Analysis: Biosimulation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different delivery model, product, application, end use, and regions for the biosimulation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biosimulation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the biosimulation market size?

Answer: The global biosimulation market is expected to reach an estimated $6.8 billion by 2030.

Q2. What is the growth forecast for biosimulation market?

Answer: The global biosimulation market is expected to grow with a CAGR of 13.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the biosimulation market?

Answer: The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software and increasing r&d expenditures in the biotechnology and pharmaceutical sectors.

Q4. What are the major segments for biosimulation market?

Answer: The future of the biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research institution markets.

Q5. Who are the key biosimulation market companies?

Answer: Some of the key biosimulation companies are as follows.

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata

Q6. Which biosimulation market segment will be the largest in future?

Answer: Lucintel forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.

Q7. In biosimulation market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biosimulation market by delivery model (subscription models and ownership models), product (software and services), application (drug development, drug discovery, and others), end use (pharmaceutical & biotechnology companies, CROs, regulatory authorities, and academic research institutions), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biosimulation Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biosimulation Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biosimulation Market by Delivery Model
    • 3.3.1: Subscription Models
    • 3.3.2: Ownership Models
  • 3.4: Global Biosimulation Market by Product
    • 3.4.1: Software
    • 3.4.2: Services
  • 3.5: Global Biosimulation Market by Application
    • 3.5.1: Drug Development
    • 3.5.2: Drug Discovery
    • 3.5.3: Others
  • 3.6: Global Biosimulation Market by End Use
    • 3.6.1: Pharmaceutical & Biotechnology Companies
    • 3.6.2: CROs
    • 3.6.3: Regulatory Authorities
    • 3.6.4: Academic Research Institutions

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biosimulation Market by Region
  • 4.2: North American Biosimulation Market
    • 4.2.1: North American Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.2.2: North American Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
  • 4.3: European Biosimulation Market
    • 4.3.1: European Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.3.2: European Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
  • 4.4: APAC Biosimulation Market
    • 4.4.1: APAC Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.4.2: APAC Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
  • 4.5: ROW Biosimulation Market
    • 4.5.1: ROW Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.5.2: ROW Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biosimulation Market by Delivery Model
    • 6.1.2: Growth Opportunities for the Global Biosimulation Market by Product
    • 6.1.3: Growth Opportunities for the Global Biosimulation Market by Application
    • 6.1.4: Growth Opportunities for the Global Biosimulation Market by End Use
    • 6.1.5: Growth Opportunities for the Global Biosimulation Market by Region
  • 6.2: Emerging Trends in the Global Biosimulation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biosimulation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biosimulation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Certara
  • 7.2: Dassault
  • 7.3: Advanced Chemistry Development
  • 7.4: Simulation
  • 7.5: Schrodinger
  • 7.6: Chemical Computing Group
  • 7.7: Physiomics
  • 7.8: Rosa & Co
  • 7.9: BioSimulation Consulting
  • 7.10: Genedata